110 related articles for article (PubMed ID: 3652924)
1. Rational design of bis-intercalating drugs as antitumour agents: importance of rigidity in the linking chain.
Garbay-Jaureguiberry C; Esnault C; Delepierre M; Laugaa P; Laalami S; Le Pecq JB; Roques BP
Drugs Exp Clin Res; 1987; 13(6):353-7. PubMed ID: 3652924
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the size and position of substituents on 7H-pyrido[4,3-c]carbazole monomers and dimers and their DNA binding and anti-tumor properties.
Léon P; Garbay-Jaureguiberry C; Le Pecq JB; Roques BP
Anticancer Drug Des; 1988 Jun; 3(1):1-13. PubMed ID: 3382504
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the bis-intercalating complexes formed between either ditercalinium or a flexible analogue and d(CpGpCpG)2 or d(TpTpCpGpCpGpApA)2 minihelices: 1H- and 31P-NMR analyses.
Pothier J; Delepierre M; Barsi MC; Garbay-Jaureguiberry C; Igolen J; Le Bret M; Roques BP
Biopolymers; 1991 Oct; 31(11):1309-23. PubMed ID: 1777582
[TBL] [Abstract][Full Text] [Related]
4. DNA bis-intercalators as new anti-tumour agents: modulation of the anti-tumour activity by the linking chain rigidity in the ditercalinium series.
Garbay-Jaureguiberry C; Laugâa P; Delepierre M; Laalami S; Muzard G; Le Pecq JB; Roques BP
Anticancer Drug Des; 1987 Apr; 1(4):323-35. PubMed ID: 3450302
[TBL] [Abstract][Full Text] [Related]
5. 1H and 31P nuclear magnetic resonance studies of the differences in DNA deformation induced by anti-tumoral 7H-pyrido[4,3-c]carbazole dimers.
Delepierre M; Maroun R; Garbay-Jaureguiberry C; Igolen J; Roques BP
J Mol Biol; 1989 Nov; 210(1):211-28. PubMed ID: 2585517
[TBL] [Abstract][Full Text] [Related]
6. Asymmetrical bisintercalators as potential antitumor agents.
Léon P; Garbay-Jaureguiberry C; Lambert B; Le Pecq JB; Roques BP
J Med Chem; 1988 May; 31(5):1021-6. PubMed ID: 3283364
[TBL] [Abstract][Full Text] [Related]
7. Recognition by the DNA repair system of DNA structural alterations induced by reversible drug-DNA interactions.
Lambert B; Segal-Bendirdjian E; Esnault C; Le Pecq JB; Roques BP; Jones B; Yeung AT
Anticancer Drug Des; 1990 Feb; 5(1):43-53. PubMed ID: 2180423
[TBL] [Abstract][Full Text] [Related]
8. DNA intercalating compounds as potential antitumor agents. 2. Preparation and properties of 7H-pyridocarbazole dimers.
Pelaprat D; Delbarre A; Le Guen I; Roques BP; Le Pecq JB
J Med Chem; 1980 Dec; 23(12):1336-43. PubMed ID: 7452686
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of new dimers in the 7H-pyrido[4,3-c] carbazole antitumor series.
Garbay-Jaureguiberry C; Barsi MC; Jacquemin-Sablon A; Le Pecq JB; Roques BP
J Med Chem; 1992 Jan; 35(1):72-81. PubMed ID: 1732535
[TBL] [Abstract][Full Text] [Related]
10. Functionalized and [a]-anellated carbazoles as potential B-DNA ligands: experimental studies of DNA binding and molecular modeling of intercalation complexes.
Pindur U; Marotto A; Schulze E; Fischer G
Pharmazie; 2000 Oct; 55(10):727-32. PubMed ID: 11082831
[TBL] [Abstract][Full Text] [Related]
11. Bis-pyridoquinolines as new bifunctional intercalators for DNA.
Malesani G; Chiarelotto G; Ferlin MG; Bordin F; Baccichetti F; Carlassare F; Vedaldi D; Dall'Acqua F
Farmaco Sci; 1984 Nov; 39(11):925-34. PubMed ID: 6519263
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the antitumor activity by methyl substitutions in the series of 7H-pyridocarbazole monomers and dimers.
Léon P; Garbay-Jaureguiberry C; Barsi MC; Le Pecq JB; Roques BP
J Med Chem; 1987 Nov; 30(11):2074-80. PubMed ID: 3669015
[TBL] [Abstract][Full Text] [Related]
13. Cytokinetic effects of bifunctional antitumor intercalator ditercalinium on Friend erythroleukemia cells.
Traganos F; Bueti C; Melamed MR; Darzynkiewicz Z
Leukemia; 1987 May; 1(5):411-6. PubMed ID: 3478539
[TBL] [Abstract][Full Text] [Related]
14. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
15. Geometry of the antitumor drug ditercalinium bisintercalated into d(CpGpCpG)2 by 1H NMR.
Delbarre A; Delepierre M; Garbay C; Igolen J; Le Pecq JB; Roques BP
Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2155-9. PubMed ID: 3470783
[TBL] [Abstract][Full Text] [Related]
16. Selective loss of mitochondrial DNA after treatment of cells with ditercalinium (NSC 335153), an antitumor bis-intercalating agent.
Segal-Bendirdjian E; Coulaud D; Roques BP; Le Pecq JB
Cancer Res; 1988 Sep; 48(17):4982-92. PubMed ID: 2842043
[TBL] [Abstract][Full Text] [Related]
17. Antitumoral activity of trisubstituted dihydrobenzo(a)carbazoles. Part III.
Segall A; Pizzorno MT
Pharmazie; 2000 Oct; 55(10):766-7. PubMed ID: 11082840
[TBL] [Abstract][Full Text] [Related]
18. Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity.
Gatto B; Zagotto G; Sissi C; Cera C; Uriarte E; Palù G; Capranico G; Palumbo M
J Med Chem; 1996 Aug; 39(16):3114-22. PubMed ID: 8759632
[TBL] [Abstract][Full Text] [Related]
19. The synthesis, stability and biological activity of bis-intercalating bis-daunomycin hydrazones.
Phillips DR; Baguley BC; Brownlee RT; Cacioli P; Chandler CJ; Kyratzis I; Reiss JA; Scourides PA
Drug Des Deliv; 1990 Mar; 5(3):203-19. PubMed ID: 1670502
[TBL] [Abstract][Full Text] [Related]
20. Acridine dimers: influence of the intercalating ring and of the linking-chain nature on the equilibrium and kinetic DNA-binding parameters.
Markovits J; Garbay-Jaureguiberry C; Roques BP; Le Pecq JB
Eur J Biochem; 1989 Mar; 180(2):359-66. PubMed ID: 2924770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
